All In Biotech

Drug Trial Radar · NCT07018323

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients With Graves' Disease

Last checked: Nov 19, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 210 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

210

Planned (sponsor's estimate)

Start

Jun 19, 2025

Primary completion

May 2027

Study completion May 2027

Sponsor

Lead sponsor
Immunovant Sciences GmbHIndustry
Sponsor type
Industry
First posted
Jun 12, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, global, randomized, double-blind, placebo-controlled Phase 2b study to assess the efficacy, safety, and tolerability of IMVT-1402 in adult participants with Graves' disease (GD) who are hyperthyroid despite antithyroid drug (ATD) treatment.

Conditions

  • Graves' Disease

Interventions

  • IMVT-1402Drug

    Dose 1 for 26 weeks

  • IMVT-1402Drug

    Dose 2 for 26 weeks

  • PlaceboDrug

    For 26 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of participants who are euthyroid and off ATD at Week 26 (Dose 1)Time frame: Week 26

Locations

163 sites in 18 countries. Site status is shown where the registry gives one.

  • Site Number - 1015

    Tucson, Arizona · Recruiting

  • Site Number -1014

    Concord, California · Recruiting

  • Site Number - 1013

    Aurora, Colorado · Recruiting

  • Site Number - 1024

    Doral, Florida · Recruiting

  • Site Number - 1008

    Hialeah, Florida · Recruiting

  • Site Number - 1000

    Miami, Florida · Recruiting

  • Site Number - 1020

    Columbus, Georgia · Recruiting

  • Site Number - 1022

    Topeka, Kansas · Recruiting

  • Site Number - 1030

    Louisville, Kentucky · Recruiting

  • Site Number - 1033

    Jefferson City, Missouri · Recruiting

  • Site Number - 1004

    Kansas City, Missouri · Recruiting

  • Site Number - 1019

    St Louis, Missouri · Recruiting

  • Site Number - 1012

    Reno, Nevada · Recruiting

  • Site Number - 1032

    Long Island City, New York · Recruiting

  • Site Number - 1027

    New Hyde Park, New York · Recruiting

  • Site Number - 1009

    New York, New York · Withdrawn

  • Site Number - 1018

    Williamsville, New York · Recruiting

  • Site Number - 1010

    Chapel Hill, North Carolina · Recruiting

  • Site Number - 1026

    Hickory, North Carolina · Recruiting

  • Site Number - 1001

    Morehead City, North Carolina · Recruiting

  • Site Number - 1034

    Raleigh, North Carolina · Recruiting

  • Site Number - 1007

    Oklahoma City, Oklahoma · Recruiting

  • Site Number - 1017

    Memphis, Tennessee · Recruiting

  • Site Number - 1029

    Dallas, Texas · Recruiting

  • Site Number - 1002

    El Paso, Texas · Recruiting

  • Site Number - 1003

    Fort Worth, Texas · Recruiting

  • Site Number - 1031

    Houston, Texas · Recruiting

  • Site Number - 1028

    Houston, Texas · Recruiting

  • Site Number -1023

    Irving, Texas · Completed

  • Site Number - 1021

    Irving, Texas · Recruiting

  • Site Number - 1025

    McKinney, Texas · Recruiting

  • Site Number - 1011

    San Antonio, Texas · Recruiting

  • Site Number - 1016

    Norfolk, Virginia · Recruiting

  • Site Number - 5108

    Perth, Australia · Recruiting

  • Site Number - 5109

    Saint Leonards, Australia · Recruiting

  • Site Number - 5105

    Sydney, New South Wales, Australia · Recruiting

  • Site Number - 5103

    Warrawong, New South Wales, Australia · Recruiting

  • Site Number - 5101

    Brisbane, Queensland, Australia · Recruiting

  • Site Number - 5107

    Douglas, Queensland, Australia · Recruiting

  • Site Number - 5100

    Southport, Queensland, Australia · Recruiting

Showing 40 of 163 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.